Which has preferable valuation and earnings, CCLDO or ACONW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $124.14M N/A N/A N/A N/A Aclarion $83.77K N/A N/A N/A N/A

Is CCLDO or ACONW more profitable?

Company Net Margins Return on Equity Return on Assets CareCloud N/A N/A N/A Aclarion N/A N/A N/A

Which has higher valuation & earnings, ONMDW or ACONW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OneMedNet $1.32M N/A N/A N/A N/A Aclarion $83.77K N/A N/A N/A N/A

Is ONMDW or ACONW more profitable?

Company Net Margins Return on Equity Return on Assets OneMedNet N/A N/A N/A Aclarion N/A N/A N/A

Which has better earnings & valuation, ACONW or VSEEW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $83.77K N/A N/A N/A N/A VSee Health $14.46M N/A N/A N/A N/A

Is ACONW or VSEEW more profitable?

Company Net Margins Return on Equity Return on Assets Aclarion N/A N/A N/A VSee Health N/A N/A N/A

Do analysts rate VEEV or ACONW?

Veeva Systems currently has a consensus price target of $247.08, suggesting a potential upside of 5.47%. Given Veeva Systems' stronger consensus rating and higher possible upside, equities research analysts clearly believe Veeva Systems is more favorable than Aclarion. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veeva Systems 1 Sell rating(s) 8 Hold rating(s) 18 Buy rating(s) 1 Strong Buy rating(s) 2.68 Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, VEEV or ACONW?

Veeva Systems has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veeva Systems $3.20B 11.91 $908.91M $5.61 41.76 Aclarion $83.77K N/A N/A N/A N/A

Do analysts recommend ACONW or WAY?

Waystar has a consensus target price of $35.23, suggesting a potential upside of 42.62%. Given Waystar's stronger consensus rating and higher possible upside, analysts clearly believe Waystar is more favorable than Aclarion. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Waystar 1 Sell rating(s) 2 Hold rating(s) 18 Buy rating(s) 3 Strong Buy rating(s) 2.96

Which has preferable earnings and valuation, ACONW or WAY?

Waystar has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $83.77K N/A N/A N/A N/A Waystar $1.10B 4.31 $112.09M $0.70 35.29

Is ACONW or WAY more profitable?

Waystar has a net margin of 11.18% compared to Aclarion's net margin of 0.00%. Waystar's return on equity of 7.03% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion N/A N/A N/A Waystar 11.18% 7.03% 4.75%

Aclarion (ACONW) Competitors

$0.03 +0.00 (+8.10%)

As of 08/10/2026 01:48 PM Eastern

Compare

ACONW vs. CCLDO, ONMDW, VSEEW, VEEV, and WAY

Should you buy Aclarion stock or one of its competitors? Aclarion's main competitors and comparable companies include CareCloud (CCLDO), OneMedNet (ONMDW), VSee Health (VSEEW), Veeva Systems (VEEV), and Waystar (WAY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Aclarion compare to CareCloud?

CareCloud (NASDAQ:CCLDO) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

In the previous week, CareCloud had 3 more articles in the media than Aclarion. MarketBeat recorded 3 mentions for CareCloud and 0 mentions for Aclarion. CareCloud's average media sentiment score of 0.40 beat Aclarion's score of 0.00 indicating that CareCloud is being referred to more favorably in the media.

Company	Overall Sentiment
CareCloud	Neutral
Aclarion	Neutral

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	N/A	N/A	N/A
Aclarion	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$124.14M	N/A	N/A	N/A	N/A
Aclarion	$83.77K	N/A	N/A	N/A	N/A

Summary

CareCloud beats Aclarion on 3 of the 3 factors compared between the two stocks.

How does Aclarion compare to OneMedNet?

OneMedNet (NASDAQ:ONMDW) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, media sentiment and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.32M	N/A	N/A	N/A	N/A
Aclarion	$83.77K	N/A	N/A	N/A	N/A

In the previous week, OneMedNet's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score.

Company	Overall Sentiment
OneMedNet	Neutral
Aclarion	Neutral

Company	Net Margins	Return on Equity	Return on Assets
OneMedNet	N/A	N/A	N/A
Aclarion	N/A	N/A	N/A

Summary

OneMedNet beats Aclarion on 1 of the 1 factors compared between the two stocks.

How does Aclarion compare to VSee Health?

Aclarion (NASDAQ:ACONW) and VSee Health (NASDAQ:VSEEW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$83.77K	N/A	N/A	N/A	N/A
VSee Health	$14.46M	N/A	N/A	N/A	N/A

In the previous week, Aclarion's average media sentiment score of 0.00 equaled VSee Health'saverage media sentiment score.

Company	Overall Sentiment
Aclarion	Neutral
VSee Health	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	N/A	N/A	N/A
VSee Health	N/A	N/A	N/A

Summary

VSee Health beats Aclarion on 1 of the 1 factors compared between the two stocks.

How does Aclarion compare to Veeva Systems?

Veeva Systems (NYSE:VEEV) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

Veeva Systems has a net margin of 28.37% compared to Aclarion's net margin of 0.00%. Veeva Systems' return on equity of 13.72% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veeva Systems	28.37%	13.72%	11.31%
Aclarion	N/A	N/A	N/A

88.2% of Veeva Systems shares are owned by institutional investors. 10.6% of Veeva Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Veeva Systems has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veeva Systems	$3.20B	11.91	$908.91M	$5.61	41.76
Aclarion	$83.77K	N/A	N/A	N/A	N/A

In the previous week, Veeva Systems had 18 more articles in the media than Aclarion. MarketBeat recorded 18 mentions for Veeva Systems and 0 mentions for Aclarion. Veeva Systems' average media sentiment score of 0.96 beat Aclarion's score of 0.00 indicating that Veeva Systems is being referred to more favorably in the media.

Company	Overall Sentiment
Veeva Systems	Positive
Aclarion	Neutral

Veeva Systems currently has a consensus price target of $247.08, suggesting a potential upside of 5.47%. Given Veeva Systems' stronger consensus rating and higher possible upside, equities research analysts clearly believe Veeva Systems is more favorable than Aclarion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veeva Systems	1 Sell rating(s)	8 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	2.68
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Veeva Systems beats Aclarion on 12 of the 12 factors compared between the two stocks.

How does Aclarion compare to Waystar?

Aclarion (NASDAQ:ACONW) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

Waystar has a consensus target price of $35.23, suggesting a potential upside of 42.62%. Given Waystar's stronger consensus rating and higher possible upside, analysts clearly believe Waystar is more favorable than Aclarion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Waystar	1 Sell rating(s)	2 Hold rating(s)	18 Buy rating(s)	3 Strong Buy rating(s)	2.96

Waystar has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$83.77K	N/A	N/A	N/A	N/A
Waystar	$1.10B	4.31	$112.09M	$0.70	35.29

In the previous week, Waystar had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for Waystar and 0 mentions for Aclarion. Waystar's average media sentiment score of 1.34 beat Aclarion's score of 0.00 indicating that Waystar is being referred to more favorably in the news media.

Company	Overall Sentiment
Aclarion	Neutral
Waystar	Positive

Waystar has a net margin of 11.18% compared to Aclarion's net margin of 0.00%. Waystar's return on equity of 7.03% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	N/A	N/A	N/A
Waystar	11.18%	7.03%	4.75%

Summary

Waystar beats Aclarion on 10 of the 10 factors compared between the two stocks.

Get Aclarion News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACONW vs. The Competition

Export

Metric	Aclarion	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$1.52B	$7.02B	$12.98B
Dividend Yield	N/A	4.71%	2.58%	10.07%
P/E Ratio	N/A	23.86	269.20	24.72
Price / Sales	N/A	72.77	588.81	98.32
Price / Cash	N/A	30.51	28.89	37.42
Price / Book	N/A	5.35	11.27	6.42
Net Income	N/A	-$25.90M	$3.45B	$347.03M
7 Day Performance	N/A	5.68%	1.92%	0.69%
1 Month Performance	N/A	3.06%	-0.58%	-0.90%
1 Year Performance	N/A	-14.72%	75.49%	21.87%

Aclarion Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACONW Aclarion	N/A	$0.03 +8.1%	N/A	-10.4%	$0.00	$83.77K	N/A	7
CCLDO CareCloud	N/A	$27.44 flat	N/A	N/A	$0.00	$124.14M	N/A	4,100	Gap Down
ONMDW OneMedNet	N/A	$0.04 -13.3%	N/A	+118.5%	$0.00	$1.32M	N/A	20	Gap Up
VSEEW VSee Health	N/A	$0.02 -2.4%	N/A	N/A	$0.00	$14.46M	N/A	N/A
VEEV Veeva Systems	3.4956 of 5 stars	$209.60 +2.9%	$247.08 +17.9%	-17.1%	$34.07B	$3.20B	37.39	7,928

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACONW) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aclarion (ACONW) Competitors